Cronos Group Inc vs Smith & Nephew plc — how do they compare? Cronos Group Inc trades at $3.08 (market cap $1.14B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: Smith & Nephew plc is far larger — about 11× Cronos Group Inc's market cap, and Smith & Nephew plc pays a 2.65% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRON | SNN | |
|---|---|---|
Market Cap | $1.14B | $12.54B |
Sector | Health | Health |
52-Week High | $3.27 | $38.70 |
52-Week Low | $2.30 | $28.73 |
Enterprise Value | $341.13M | $15.57B |
Dividend Yield | — | 2.65% |
Trailing returns across standard periods
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →